Conchinin
Categoria
Conchinin Marchi, Conchinin Analoghi
- Apo-Quinidine
- Biquin Durules
- Cardioquin
- Chinidin
- Cin-Quin
- Coccinine
- Conchinin
- Conchinine
- Conquinine
- Duraquin
- Kinidin
- Novoquinidin
- Pitayin
- Pitayine
- Quin-Release
- Quinact
- Quinaglute
- Quinaglute Dura-Tabs
- Quinalan
- Quinate
- Quinatime
- Quindine
- Quinicardine
- Quinidex
- Quinidex Extentabs
- Quinidine Gluconate
- Quinidine Sulfate
- Quinine, Polymers
- Quinora
Conchinin Marchi miscela
Conchinin Formula chimica
C20H24N2O2
Conchinin RX link
http://www.rxlist.com/cgi/generic/quinidine.htm
Conchinin FDA foglio
Conchinin DMS (foglio di materiale di sicurezza)
Conchinin Sintesi di riferimento
Nessuna informazione disponibile
Conchinin Peso molecolare
324.417 g/mol
Conchinin Temperatura di fusione
174 oC
Conchinin H2O Solubilita
140 mg / L
Conchinin Stato
Solid
Conchinin LogP
2.534
Conchinin Forme di dosaggio
Soluzione
Conchinin Indicazione
Per il trattamento di pre-eccitazione ventricolare e aritmie cardiache
Conchinin Farmacologia
Chinidina, un anticonvulsivo idantoina, รจ usato da solo o con anticonvulsivanti fenobarbital o altro per gestire crisi tonico-cloniche, crisi psicomotoria, sindromi da dolore neuropatico diabetico compresi neuropatia, aritmie cardiache indotte da digitale, e aritmie cardiache associate a prolungamento dell'intervallo QT.
Conchinin Assorbimento
Nessuna informazione disponibile
Conchinin Tossicita
Nessuna informazione disponibile
Conchinin Informazioni paziente
Before prescribing QUINAGLUTE® as prophylaxis against recurrence of atrial fibrillation, the physician should inform the patient of the risks and benefits to be expected. Discussion should include the facts
- that the goal of therapy will be a reduction (probably not to zero) in the frequency of episodes of atrial fibrillation; and
- that reduced frequency of fibrillatory episodes may be expected, if achieved, to bring symptomatic benefit; but
- that no data are available to show that reduced frequency of fibrillatory episodes will reduce the risks of irreversible harm through stroke or death; and in fact
- that such data as are available suggest that treatment with QUINAGLUTE® is likely to increase the patient's risk of death.
To confirm whether this is the most current prescribing information available on Quinaglute®, or to obtain the most current prescribing information, please call Berlex Laboratories at 1-888-BERLEX-4 (choose option #4, Product Usage Information).
Conchinin Atto interessato organismi
Gli esseri umani e altri mammiferi
